9/7/2005

Amgen said the FDA approved new manufacturing plants, with Amgen's Enbrel to be produced at a plant in Rhode Island and Neupogen and Neulasta to be manufactured at a new plant in Puerto Rico. The company also said it was building a second facility at the Puerto Rico site for production of its anemia drug, Epogen.

Full Story:
Reuters

Related Summaries